4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-24-010723
Chief Operating Officer gave up 3,098 shares (to pay taxes)
- Chief Operating Officer acquired 8,952 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cittadine Andrew Chief Operating Officer | 2024-03-31 | Option exercise | +8,952 | 60,722 | D | ||
| Cittadine Andrew Chief Operating Officer | 2024-03-31 | Shares withheld for taxes | −3,098 | $0.68 | $2,110 | 57,624 | D |
| Derivatives | |||||||
| Cittadine Andrew Chief Operating Officer | 2024-03-31 | Option exercise · Restricted Stock Units | −8,952 | 82,223 | D | ||
Loading xslF345X05/rdgdoc.xml…